Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in MiceWilliam T. Rothwell, James M. Wilson, Peter Bell et al.|Cancer Research|2018Cited by 19
Suppl Fig 9 from Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in MiceWilliam T. Rothwell, James M. Wilson, Peter Bell et al.|Unknown|2023Cited by 0
Suppl Fig 6 from Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in MiceWilliam T. Rothwell, James M. Wilson, Mingyao Li et al.|Unknown|2023Cited by 0
Suppl Fig 3 from Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in MiceWilliam T. Rothwell, James M. Wilson, Peter Bell et al.|Unknown|2023Cited by 0
Suppl Figs 4+5 from Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in MiceWilliam T. Rothwell, James M. Wilson, Peter Bell et al.|Unknown|2023Cited by 0